Extreme ecchymoses in a migraine patient using concomitant treatment with calcitonin gene-related peptide receptor antibodies and fish oil supplements: a case report

Abstract Background Erenumab, a monoclonal antibody against the calcitonin gene-related peptide (CGRP) receptor, is registered for migraine prevention. Compared to other conventional migraine prevention medicines (i.e. topiramate, betablockers and amitriptyline) erenumab has better tolerability. Imp...

詳細記述

書誌詳細

出版年:	BMC Neurology
主要な著者:	C. K. Cullum, M. K. Olsen, H. B. Kocadag, M. Ashina, F. M. Amin
フォーマット:	論文
言語:	英語
出版事項:	BMC 2021-07-01
主題:	Migraine Erenumab CGRP monoclonal antibody Fish oil Ecchymosis Bleeding
オンライン･アクセス:	https://doi.org/10.1186/s12883-021-02294-6